VAM
MRK icon

Verity Asset Management’s Merck MRK Stock Holding History

Verity Asset Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.15M Sell
8,942
-260
-3% -$30.4K 0.43% 67
2026
Q1 		$1.11M Buy
9,202
+476
+5% +$55K 0.46% 64
2025
Q4 		$918K Buy
8,726
+187
+2% +$17.6K 0.39% 67
2025
Q3 		$717K Buy
8,539
+159
+2% +$13.1K 0.23% 102
2025
Q2 		$663K Sell
8,380
-19
-0.2% -$1.51K 0.32% 81
2025
Q1 		$754K Sell
8,399
-375
-4% -$35K 0.31% 94
2024
Q4 		$779K Buy
8,774
+526
+6% +$54.2K 0.44% 58
2024
Q3 		$932K Buy
8,248
+611
+8% +$72.6K 0.35% 76
2024
Q2 		$946K Buy
7,637
+2
+0% +$258 0.37% 66
2024
Q1 		$1.01M Buy
7,635
+2
+0% +$247 0.56% 42
2023
Q4 		$832K Sell
7,633
-35
-0.5% -$3.63K 0.53% 48
2023
Q3 		$789K Sell
7,668
-215
-3% -$23.2K 0.58% 48
2023
Q2 		$910K Buy
7,883
+25
+0.3% +$2.84K 0.67% 41
2023
Q1 		$836K Buy
7,858
+361
+5% +$39K 0.5% 60
2022
Q4 		$832K Sell
7,497
-2,139
-22% -$219K 0.71% 44
2022
Q3 		$830K Buy
+9,636
New +$860K 0.86% 33
2022
Q1 		$775K Buy
9,434
+1,666
+21% +$131K 0.49% 64
2021
Q4 		$595K Buy
7,768
+179
+2% +$14.3K 0.35% 81
2021
Q3 		$570K Sell
7,589
-708
-9% -$53.8K 0.37% 78
2021
Q2 		$645K Buy
8,297
+505
+6% +$37.6K 0.35% 80
2021
Q1 		$573K Buy
7,792
+915
+13% +$67.5K 0.34% 86
2020
Q4 		$537K Buy
6,877
+1,038
+18% +$79.4K 0.37% 74
2020
Q3 		$462K Buy
5,839
+441
+8% +$34.5K 0.35% 70
2020
Q2 		$306K Buy
5,398
+961
+22% +$72.3K 0.28% 89
2020
Q1 		$326K Buy
4,437
+1,911
+76% +$150K 0.41% 76
2019
Q4 		$219K Buy
+2,526
New +$207K 0.22% 114

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Verity Asset Management's MRK Position: Q2 2026 in Review

Verity Asset Management reduced its Merck (MRK) stake by 2.8% in Q2 2026, selling an estimated $30.4K and leaving 8,942 shares worth $1.15M. The position accounts for 0.43% of the portfolio, ranked #67.

Verity Asset Management first reported a position in MRK in Q4 2019 and has held it in 26 quarters since. 3,842 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Verity Asset Management held 8,942 shares of Merck worth $1.15M as of Q2 2026.
  • Verity Asset Management sold 260 Merck shares in Q2 2026, an estimated $30.4K.
  • Merck made up 0.43% of Verity Asset Management's portfolio in Q2 2026, its #67 holding.
  • Verity Asset Management first reported a position in Merck in Q4 2019 and has held it in 26 quarters since.
  • 3,842 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Verity Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.